JOB vs RTX

The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. While the balance sheet shows strong liquidity (Current Ratio 5.32) and very low leverage (Debt/Equity 0.08), these are offset by deteriorating operations, including a -14.60% YoY revenue decline and a dismal ROE of -51.07%. The low valuation metrics (P/B 0.50, P/S 0.27) appear to be a value trap rather than a discount, as the company is shrinking and consistently unprofitable. Technical trends are completely bearish (0/100), suggesting no immediate market confidence.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.